Enhanced expression of dystrophin, IGF-1, CD44 and MYH3 in plasma and skeletal muscles including diaphragm of mdx mice after oral administration of Neu REFIX beta 1,3-1,6 glucan - Preethy, Senthilkumar; Sakamoto, Shuji; Higuchi, Takuma; Ichiyama, Koji; Yamamoto, Naoki; Ikewaki, Nobunao; Iwasaki, Masaru; Dedeepiya, Vidyasagar Devaprasad; Srinivasan, Subramaniam; Raghavan, Kadalraja; Rajmohan, Mathaiyan; Senthilkumar, Rajappa; et al. (Scientific reports, 2025)
Keywords: 692/699; 692/699/375/374; Administration, Oral; Animals; CD44; CD44 antigen; Diaphragm; Diaphragm - drug effects; Diaphragm - metabolism; Duchenne muscular dystrophy (DMD); Duchenne's muscular dystrophy; Dystrophin; Dystrophin - blood; Dystrophin - metabolism; Dystrophy; Enzyme-linked immunosorbent assay; Genetic disorders; Glucans - administration & dosage; Glucans - pharmacology; Humanities and Social Sciences; Hyaluronan Receptors - blood; Hyaluronan Receptors - metabolism; Immunohistochemistry; Insulin-like growth factor I; Insulin-Like Growth Factor I - metabolism; Insulin-like growth factors; Male; mdx mice; Mice; Mice, Inbred mdx; multidisciplinary; Muscle, Skeletal - drug effects; Muscle, Skeletal - metabolism; Muscles; Muscular Dystrophy, Duchenne - drug therapy; Muscular Dystrophy, Duchenne - metabolism; MYH3; Myosin Heavy Chains - blood; Myosin Heavy Chains - metabolism; Oral administration; Plasma; Science; Science (multidisciplinary); Skeletal muscle; β-Glucan; MYH3; Duchenne muscular dystrophy (DMD); IGF-1; β-Glucan; mice; Dystrophin; CD44; mdx mice